Form 4: Aspira Women's Health Director Exercises Restricted Stock Units

Director John Phillip Ragard converted 4,844 restricted stock units into common stock of Aspira Women's Health on December 31, 2024.

Summary

• John Phillip Ragard, a director at Aspira Women's Health, converted 4,844 restricted stock units (RSUs) into common stock on December 31, 2024.
• These RSUs were part of a grant of 19,375 RSUs awarded on August 22, 2024, with 4,844 vesting on December 31, 2024.
• The conversion resulted in Mr. Ragard owning 125,047 shares of common stock directly.
• The RSUs were converted at a price of $0, as they represent the right to receive shares upon vesting.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to executive compensation. It is neither particularly positive nor negative, but rather an expected event.

Industry Context

This is a routine transaction for a company with stock-based compensation plans. It is common for directors and officers to receive and vest restricted stock units.

Comparison to Industry Standards

• Stock-based compensation, including restricted stock units, is a common practice across the biotechnology and healthcare industries.
• Many companies use RSUs to align the interests of management and shareholders.
• The vesting schedule and terms of the RSUs are typical for executive compensation packages.

Stakeholder Impact

• The transaction increases the number of shares held by a director, which could have a minor impact on the overall share structure.

Key Dates

Keywords

restricted stock units, RSU, stock conversion, insider trading, beneficial ownership, Aspira Women's Health, director